This trial will test if a drug called MitoQ can help reduce fatigue in MS patients.
- Multiple Sclerosis
1 Primary · 3 Secondary · Reporting Duration: 12 weeks
3 Treatment Groups
40mg of MitoQ
1 of 3
20mg of MitoQ
1 of 3
1 of 3
60 Total Participants · 3 Treatment Groups
Primary Treatment: 40mg of MitoQ · Has Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 18 - 70 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|VA Portland Health Care System, Portland, OR||100.0%|
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
Could I be a suitable participant in this experiment?
"To participate in this medical trial, those with multiple sclerosis and aged between 18 to 70 years of age are eligible. A maximum of 60 patients can join the study." - Anonymous Online Contributor
Are individuals of all ages being considered for participation in this medical experiment?
"According to the prerequisites of this clinical test, participants must be at least 18 years old and no older than 70." - Anonymous Online Contributor
How many individuals have taken part in the research?
"Correct. The information hosted on clinicaltrials.gov asserts that this medical trial, which was originally posted in April 1st 2020, is currently looking for participants to join the study. In total 60 patients will be recruited from one location." - Anonymous Online Contributor
Is this research endeavor actively recruiting participants at the moment?
"Affirmative. According to information hosted on clinicaltrials.gov, this investigation is actively seeking volunteers for enrollment. It was first published in April 1st 2020 and has been recently updated on April 15th 2022; with the aim of finding 60 participants from one medical centre." - Anonymous Online Contributor